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Ultrafiltration failure (UFF) is a serious complication of
peritoneal dialysis (PD). The aim of the study was to analyze
changes in water transport and their determinants in
UFF patients over the time on PD. Standard peritoneal
permeability analyses of 50 stable PD patients with UFF were
analyzed. Fluid transport through small pores (SPT), free
water transport (FWT) at 60 min, their contributions on total
ultrafiltration (SPTC and FWTC), and their determinants were
assessed. Patients were divided in Group I (UFF) treated for
less than 24 months, Group II treated 24–60 months, and
Group III treated for more than 60 months. Group I (UFF) was
compared with Group I (non-UFF) matched for the duration
of PD treatment and age. Transcapillary ultrafiltration (TCUF),
SPT, FWT, and FWTC were significantly lower in Group III
when compared to the other UFF groups. In this group
also, negative relationship was present between FWT, the
ultrafiltration coefficient LpA, and osmotic conductance to
glucose on one hand and PD duration on the other. FWT was
positively related to osmotic conductance to glucose in all
groups. Group I (UFF) showed significantly higher solute
transport, effective lymphatic absorption rate, lower TCUF,
and lower FWT than Group I (non-UFF). The patterns of UFF
in PD patients are dependent on the duration of treatment.
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Ultrafiltration failure (UFF) is a serious complication of
peritoneal dialysis (PD), often resulting in the necessity to
discontinue the treatment. The risk of ultrafiltration loss
increases with time on PD.1–3 A reduced drained volume can
have non-membrane-related causes, such as catheter disloca-
tion or a subcutaneous leak. Besides, membrane-related
mechanisms can be present. The presence of a large vascular
surface area, as suggested by high mass transfer area
coefficient (MTAC) of low molecular weight solutes, is the
most frequent cause of UFF. Other factors are a high fluid
absorption rate of an intraperitoneally (i.p.) administered
volume marker (effective lymphatic absorption rate (ELAR)),
both by transmesothelial transport and lymphatic uptake,
and a decreased osmotic conductance to glucose.2,4,5 A
combination of factors may occur.
Our previous study has shown different prevalences of
individual factors responsible for UFF depending on the time
of the development of this complication.6 A decreased
osmotic conductance to glucose in combination with an
increased vascular peritoneal surface area was a frequent
cause of UFF in long-term patients, whereas a high ELAR was
an important factor in short-term patients.
The aim of this study was to analyze changes in water
transport in patients with UFF and their relationship with the
time of development of this complication. Furthermore, the
relationship between the osmotic conductance to glucose and
free water transport (FWT) over the time on PD was
investigated. In addition, a comparison of water transport
determinants patients with UFF treated with PD for less than
2 years and matched control patients without this complica-
tion was performed.
RESULTS
Solute and fluid transport characteristics and their determi-
nants are given in Table 1 for the three patient groups with
UFF. Effective lymphatic absorption and total transcapillary
ultrafiltration (TCUF) were significantly lower in the
patients on PD for more than 5 years. This was also the
case for TCUF after the first hour, small pore fluid transport
at 60 min, and FWT. The ultrafiltration coefficient and the
osmotic conductance to glucose were significantly lower in
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Group III, whereas no difference was present in the reflection
coefficient for glucose. Solute transport parameters, except
MTACcreat, were not different between patients of Groups I
and II. MTACcreat was significantly lower in patients of Group
I compared to the other groups, whereas no difference was
present between Groups II and III.
In Table 2, a comparison of solute and fluid transport
parameters between patients with and without UFF treated
for less than 2 years is given. Group I (UFF) showed a
significantly higher solute transport, ELAR, and lower TCUF
than Group I (non-UFF). Except for FWT, which was
significantly lower in Group I (UFF), the contributions of
FWT and small pore fluid transport were not different. Also
LpA and sigma were not different between the patients with
and without UFF.
Relationships between the duration of PD and parameters
of fluid transport at 60 min and their determinants are given
in Table 3 and shown in Figure 1. Fluid transport, osmotic
conductance, and its determinants were not related to the
duration of PD treatment in Group I (non-UFF). However, a
positive correlation was found between FWT at 60 min and
PD duration in the patients Group I (UFF). Although not
significant, a similar tendency was present between TCUF0–60
and PD duration in the same group. No associations were
found between any of these parameters and PD duration in
Group II. In the long-term patients with UFF, TCUF, FWT,
LpA, and the osmotic conductance correlated negatively with
the duration of treatment. No relationships with time were
found for small pore transport (SPT) and the reflection
coefficient.
Because both FWT and its determinants showed a negative
relationship with the duration of PD in long-term patients,
associations between these parameters were analyzed and are
shown in Table 4. FWT at 60 min was related to the osmotic
conductance in all groups. It also correlated with LpA in
patients of Group I (non-UFF and UFF) and of Group II.
Table 1 | A comparison between peritoneal solute transport, fluid kinetics, and determinants of TCUF between Group I
(PD duration o24 months), Group II (PD duration 24–60 months), and Group III (PD duration 460 months)
Group I (UFF) Group II Group III
Number of patients 22 14 14
PD duration 8 (1–23) 43 (32–59) 96 (61–154) Overall P-value
Solute and fluid transport parameters after 4 h
MTACcreat (ml/min) 12.2 (5.7–18.6) 13.3 (9.5–26.6)
a 15.0 (7.5–25.3) 0.06
GA (%) 71 (45–81) 73 (64–90) 73 (50–84) 0.28
ELAR (ml/min) 2.2 (0.4–5.0) 2.4 (1.0–6.6) 1.7 (0.3–5.0)b 0.05
TCUF (ml) 734 (21–1303) 742 (523–1310) 625 (265–1386)c,d 0.01
Water transport during the first hour
TCUF0–60 (ml) 393 (114–883) 365 (256–850) 273 (129–431)
c,d 0.01
SPT0–60 (ml) 267 (77–666) 247 (75–683) 199 (61–345)
c,d 0.01
FWT0–60 (ml) 127 (36–217) 119 (40–285) 73 (55–149)
c,d 0.02
FWTC0–60 (%) 32 (14–62) 32 (2–65) 27 (13–45)
c,d 0.01
SPTC0–60 (%) 68 (38–83) 68 (33–98) 73 (55–87) 0.11
Determinants of TCUF
LpA (ml/min/mmHg) 0.10 (0.01–0.16) 0.11 (0.05–0.21) 0.08 (0.03–0.19)b 0.05
s 0.045 (0.033–0.054) 0.042 (0.032–0.051) 0.042 (0.036–0.053) 0.31
OC (ml/min/mmHg) 4.7 (2.1–7.1) 4.6 (2.0–10.6) 3.2 (1.3–7.9)b 0.05
ELAR, effective lymphatic absorption rate; FWT0–60, free water transport within the first hour; FWTC0–60, contribution of free water transport within the first hour to the total
ultrafiltration; GA, glucose absorption; LpA, ultrafiltration coefficient; MTACcreat, mass transfer area coefficient of creatinine; OC, osmotic conductance to glucose;
PD, peritoneal dialysis; SPT0–60, small pore fluid transport within the first hour; SPTC0–60, contribution of small pore fluid transport within the first hour to the total
ultrafiltration; s, reflection coefficient for glucose; TCUF, transcapillary ultrafiltration; TCUF0–60, transcapillary ultrafiltration within the first hour.
aGroup I vs group II, Po0.06; bGroup II vs Group III, Po0.05; cGroup II vs Group III, Po0.01; dGroup I vs Group III, Po0.01.
Median values and ranges are given.
Table 2 | A comparison between patients without UFF (Group
I – non-UFF) and patients with UFF (Group I – UFF) treated for
less than 2 years, matched for PD duration and age
Group I (non-UFF) Group I (UFF)
MTACcreat (ml/min) 8.9 (2.5–15.4) 12.2 (5.7–18.6)
a
GA (%) 55 (36–75) 71 (45–81)c
ELAR (ml/min) 1.4 (0.1–3.3) 2.2 (0.4–5.0)b
TCUF (ml) 971 (377–1940) 734 (21–1303)c
TCUF0–60 (ml) 411 (159–746) 393 (114–883)
SPT0–60 (ml) 268 (71–605) 264 (77–666)
FWT0–60 (ml) 168 (48–375) 127 (36–217)
b
FWTC0–60 (%) 42 (13–63) 32 (14–62)
SPTC0–60 (%) 58 (37–87) 68 (38–83)
LpA (ml/min/mmHg) 0.10 (0.05–0.32) 0.10 (0.01–0.16)
s 0.045 (0.037–0.054) 0.045 (0.033–0.054)
OC (ml/min/mmHg) 4.5 (2.9–13.4) 4.7 (2.1–7.1)
ELAR, effective lymphatic absorption rate; FWT0–60, free water transport within the
first hour; FWTC0–60, contribution of free water transport within the first hour to the
total ultrafiltration; GA, glucose absorption; LpA, ultrafiltration coefficient; MTACcreat,
mass transfer area coefficient of creatinine; OC, osmotic conductance to glucose; PD,
peritoneal dialysis; SPT0–60, small pore fluid transport within the first hour; SPTC0–60,
contribution of small pore fluid transport within the first hour to the total
ultrafiltration; s, reflection coefficient for glucose; TCUF, transcapillary ultrafiltration;
TCUF0–60, transcapillary ultrafiltration within the first hour; UFF, ultrafiltration failure.
aPp0.05, bPp0.01, cPp0.001.
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Furthermore, in Group I (UFF) and II, a positive correlation
was found between FWT at 60 min and the reflection
coefficient.
TCUF and small pore fluid transport showed a tendency
to be higher in Group I (non-UFF) than in Group I (UFF),
especially during the second half of the dwell and this became
significant after 4 h. FWT was significantly lower in Group I
(UFF) than in Group I (non-UFF) during the whole dwell. A
comparison between Groups I (UFF), II, and III showed that
small pore fluid transport at 240 min was significantly lower
in Group III compared to the other groups. From 120 min
on, FWT was not different in the three groups. The time
courses of the fluid transport during the dwell are shown in
Figure 2.
DISCUSSION
This study on pathways of fluid transport and their
determinants in patients with UFF shows that TCUF
decreases with the time on PD, whereas MTACcreat has a
tendency to be higher in long-term patients. This suggests the
development of an enlargement of the vascular surface area.4
Also, patients with UFF during the first years of treatment
had a higher MTACcreat than their time-matched controls,
but in this group it was accompanied by a higher glucose
absorption, leading to a rapid decrease of the osmotic
Table 3 | The correlations between peritoneal fluid transport
characteristics, their determinants, and PD duration in
patients with and without UFF in each group separately
Correlation coefficient with the duration of PD
Group I (non-UFF) Group I (UFF) Group II Group III
Fluid transport at 60 min
TCUF0–60 0.17 0.37a 0.04 0.67b
SPT0–60 0.04 0.22 0.22 0.32
FWT0–60 0.07 0.56c 0.07 0.73c
LpA 0.31 0.31 0.16 0.73c
s 0.16 0.16 0.14 0.05
OC 0.27 0.35 0.08 0.84d
FWT0–60, free water transport within the first hour; Group I, PD duration less than 24
months; Group II, PD duration 24–60 months; Group III, PD duration more than 60
months; LpA, ultrafiltration coefficient; non-UFF – Group I, patients without
ultrafiltration failure treated for less than 24 months; OC, osmotic conductance to
glucose; PD, peritoneal dialysis; SPT0–60, small pore fluid transport within the first
hour; s, reflection coefficient for glucose; TCUF0–60, transcapillary ultrafiltration
within the first hour; UFF, ultrafiltration failure.
aPo0.1, bPo0.05, cPo0.01, dPo0.001.
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Figure 1 | Fluid transport determinants and their relation to the duration of PD. (a) osmotic conductance to glucose and (b) ultrafiltration
coefficient. (c) FWT within the first hour and (d) reflection coefficient for glucose. In all panels, Group I – non-UFF (&), Group I UFF (K),
Group II (m), and Group III (’) are shown. In the cases when the significant correlation between transport determinant and PD duration
was found, the regression line is depicted.
Table 4 | The correlations between FWT within the first hour
and fluid transport determinants in the three groups
Correlation coefficient with FWT0–60 (ml)
Group I (non-UFF) Group I (UFF) Group II Group III
LpA 0.42a 0.50a 0.67a 0.62
s 0.33 0.46a 0.53b 0.19
OC 0.56b 0.60b 0.78b 0.75a
FWT0–60, free water transport within the first hour; Group I, PD duration less than 24
months; Group II, PD duration 24–60 months; Group III, PD duration more than 60
months; LpA, ultrafiltration coefficient; non-UFF – Group I, patients without
ultrafiltration failure treated for less than 24 months; OC, osmotic conductance to
glucose; s, reflection coefficient for glucose; UFF, ultrafiltration failure.
aPo0.05, bPo0.01.
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gradient. However, glucose absorption was similar in UFF
patients treated for less than 2 years, when compared to those
on dialysis for a longer duration. These results suggest that
early UFF is especially associated with a large number of
perfused peritoneal vessels. It is likely that locally acting
vasoactive substances such as vascular endothelial growth
factor and interleukin-67–9 are involved in this phenomenon.
The ELAR also contributed to UFF in short-term patients,
but was significantly lower in patients treated for more than
5 years, compared to the other groups. As no time trend is
present for the ELAR,10 a selective dropout of these patients
with the highest values is likely.
FWT at 60 min was lower in short-term patients with UFF
than in patients with normal ultrafiltration. This was not
accompanied by differences in the osmotic conductance to
glucose. The dependency of FWT on the osmotic gradient11
makes it likely that the increased peritoneal perfusion is the
causative mechanism. No difference was found for SPT. This
may be explained by the results of previous studies in patients
without UFF, showing that FWT is more dependent on the
osmotic gradient than small pore fluid transport.11
TCUF decreased progressively with the duration of PD.
Consequently, patients treated for more than 5 years had
much more severe UFF than those on dialysis for a shorter
duration. This decrease consisted of a reduction in both small
pore fluid transport and FWT, but also in the contribution
of FWT to ultrafiltration. In addition, the determinants
of ultrafiltration, that is LpA and the osmotic conductance
to glucose, also decreased. This confirms a previous study
in which a decreased osmotic conductance to glucose was
identified as the main reason for UFF in long-term PD
patients.5
In all patient groups, FWT was related to the osmotic
conductance. In patients treated for less than 5 years, FWT
correlated with the determinants of the osmotic conductance,
that is, with LpA and sigma. The absence of this in Group III
suggests that other mechanisms may also be involved
in long-term patients.
Generally, no relationships were present between the
duration of PD and the fluid transport parameters in patients
treated for less than 5 years. Only TCUF and FWT showed a
positive correlation with time on PD in the patients treated
for less than 2 years. This might be caused by higher solute
transport rates in the first 6 months on PD than later on,
owing to vasoactive substances. Indeed, we previously found
a U shape for the MTACcreat and glucose absorption in
patients without UFF.11 In contrast, patients treated for more
than 5 years showed negative correlations with time for
TCUF, FWT, osmotic conductance, and LpA.
The above findings make it likely that impaired TCUF in
the first few years of PD treatment is caused by an often
temporary enlargement of the vascular peritoneal surface
area owing to a large number of perfused peritoneal vessels,
leading to a disappearance of the osmotic gradient and
thereby some reduction in FWT, but not in its contribution
to total ultrafiltration. This is compatible with pure
functional changes without anatomic abnormalities. UFF in
long-term PD is due to anatomical membrane alterations.
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Figure 2 | Peritoneal fluid kinetics for the group of patients without UFF treated for less than 2 years and three groups of patients with
UFF. (a) Fluid kinetics of patients in Group I – non-UFF (upper panel) and Group I – UFF (lower panel), (b) fluid parameters of Group II, and
(c) fluid transport in Group III. In all panels, the total TCUF during the 4 h dwell (K), net ultrafiltration (m), lymphatic absorption (’),
the transport through the small pores (&), and the FWT (J) are shown.
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Despite a progressive increase in the number of vessels, as
reflected by the MTACcreat, a rapid disappearance of the
osmotic gradient is not the only cause. On top of this, the
osmotic conductance to glucose is impaired, leading to an
absolute and relative decrease in FWT.
Besides the hydrostatic and colloid osmotic pressure
gradients, ultrafiltration during PD is determined by the
peritoneal ultrafiltration coefficient, which is a membrane-
related property, and the function of aquaporin-1 in
endothelial cells of peritoneal capillaries and venules. The
ultrafiltration coefficient consists of the hydraulic perme-
ability of the membrane (Lp) and its surface area (A). The
reflection coefficient sigma is dependent on auqporin-1
function. The osmotic conductance can mathematically be
expressed as the product of LpA and sigma. In general, the
differences in sigma between the three groups were insignifi-
cant, in contrast to LpA. As the peritoneal surface area is
likely to increase with the duration of PD, a reduction in the
hydraulic permeability of the peritoneum might be an
important factor in the decreased osmotic conductance to
glucose and FWT. However, in a previous study comparing
long-term PD patients with UFF to long-term patients
without this complication, a lower sigma was found, whereas
LpA was not significantly different.5 The reason for this
discrepancy is unclear, but obviously the design of the study
was different.
It can be concluded that the causes of UFF are different in
short- and long-term patients. A rapid disappearance of the
osmotic gradient is the main cause in short-term patients.
After 2 years, the contribution of a decreased osmotic
conductance to glucose increases, leading to impaired FWT.
It has not been established whether impaired aquaporin-1
function or decreased peritoneal water permeability is the
main factor.
MATERIALS AND METHODS
The standard peritoneal permeability analyses (SPA) of 50 stable PD
patients with UFF were studied cross-sectionally. Each patient was
studied once. Patients were considered to have UFF when net
ultrafiltration after a 4 h dwell with a 3.86% glucose dialysis solution
was less than 400 ml.12 The median age was 56 years (range 20–78
years), 44% were females. PD duration ranged from 1 to 154
months, median 33.
For further analysis, patients were divided into three groups
according to the duration of PD. Group I (UFF) consisted of 22
patients treated with PD for less than 24 months (median 8, range
1–23 months). Group II (14 patients) was on PD between 24 and 60
months (median 43, range 32–59 months) and Group III (14
patients) was treated for more than 60 months (median 96, range
61–154 months). The groups were not different with regard to age
and gender. In an additional analysis, the 22 patients of Group I
were compared with 22 patients without UFF (Group I – non-UFF),
matched for the duration of PD treatment and age.
None of the patients had peritonitis during the SPA or 1 month
prior the investigation. Thirteen patients were treated with
automated PD, the others with continuous ambulatory PD. All of
them used commercially available glucose-based dialysis solutions
(Dianeals or Physioneals, Baxter Healthcare Ltd, IRL-Dublin,
Ireland). In addition, 16 of them used 7.5% icodextrin (Extraneals,
Baxter Healthcare Ltd, IRL-Dublin, Ireland) for the long dwell. One
patient had one dwell with an amino acid-based solution
(Nutrineals, Baxter Healthcare Ltd, IRL-Dublin, Ireland). Seven
patients in the group without UFF were treated with automated PD;
all of them used commercially available glucose-based dialysis
solutions (Dianeals or Physioneals, Baxter Healthcare Ltd, IRL-
Dublin, Ireland) and were treated with 7.5% icodextrin (Extraneals,
Baxter Healthcare Ltd, IRL-Dublin, Ireland) for the long dwell.
Procedure
The SPAs were performed during a 4 h dwell with 3.86% glucose
dialysate (Dianeals) under standardized conditions as described
previously.13,14 The test itself was preceded and followed by a rinsing
procedure to avoid the possible effects of the residual volume before
the test and to calculate the residual volume at the end of the
investigation. Dextran 70 (Hyskons, Pharmacia AB, Emmer-
Compascuum, Sweden or Macrodex, NPBI, Emmer-Compascuum,
The Netherlands), 1 g/liter was added to the test solution to calculate
peritoneal fluid kinetics.15 To prevent a possible anaphylactic
reaction to this marker, 20 ml of dextran 1 (Promitens, Gynotec,
Malden, The Netherlands) was injected intravenously before
instillation of the test bag.16 Blood samples were taken at the
beginning and at the end of the SPA. The dialysate samples were
taken before the instillation and at multiple time points after inflow
of the test solution (10, 20, 30, 60, 120, 180, and 240 min).
Measurements
Dextran concentrations were determined by high-performance
liquid chromatography.17 Plasma and effluent concentrations of
urea, creatinine, and urate were measured by means of enzymatic
methods (Hitachi, Boehringer Mannheim, Germany). Sodium was
determined using the indirect ion selective electrode method.
Glucose was measured on an autoanalyzer (SMA II, Technicon,
Terrytown, NJ, USA) by the glucose oxidase-peroxidase method.
Serum albumin was measured by nephelometry (BN 100, Behring,
Marburg, Germany) with a commercial antiserum (Dakopatts,
Glostrupp, Denmark).
Calculations
Calculations were performed as described previously.13,14,18 The
TCUF, back-filtration, and lymphatic absorption result in changes in
the in situ i.p. volume during the dwell. The latter was calculated by
means of dextran dilution after correction for incomplete recov-
ery.19,20 Net ultrafiltration is the difference between the in situ i.p.
volume and the initial i.p. volume. For the measurement of the
ELAR, the disappearance of dextran from the peritoneal cavity is
used. It is calculated as the convective loss of dextran during the
dwell and expressed as peritoneal dextran clearance.20 With this
methodology, all pathways of uptake into the lymphatic system,
both subdiaphragmatic and interstitial are included. The term
effective lymphatic absorption is used because a clearance is
employed to estimate a flow rate.21 The TCUF during the dwell
was calculated by subtracting the initial in situ i.p. volume from the
theoretical i.p. volume at any time point, that is when both effective
lymphatic absorption and the sampling were neglected.15,19
Small pore fluid transport and FWT were calculated in every
patient using the convective transport of sodium, as described by La
Milia et al.22 Therefore, a correction for sodium diffusion was
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performed using the MTAC of urate.23 SPT was calculated by
multiplying the theoretical i.p. volume at any time point during the
dwell by the dialysate sodium concentration corrected for diffusion.
The time point 10 min after completion of inflow was taken as the
start value. By subtracting the amount of sodium at 10 min from the
amount at every point, the quantity of sodium transported within
each period of the dwell was calculated. The fluid transport through
the small pores at every time point was computed by dividing the
amount of transported sodium with the sodium concentration in
the small pores, that is the average of the plasma and the dialysate
sodium concentration.
At each moment, the fluid transport through the small pores was
then subtracted from the total ultrafiltered fluid volume, resulting in
FWT within every analyzed period of the dwell.18 The FWT and the
small pore fluid transport are expressed as absolute values and as
their contribution to the total ultrafiltration. The fluid volume
transported in any time interval divided by the number of minutes
in this time period resulted in the rate of fluid transport at any time
point.
MTACs of low molecular weight solutes were calculated
according to the Waniewski model.24 Solute concentrations are
expressed as the solute concentration per volume of plasma water.
Glucose absorption was calculated as the difference between the
amount of glucose instilled and the amount recovered, relative to
the amount instilled.
The TCUF rate is determined by the product of the ultrafiltration
coefficient (LpA) and the pressure gradient. For the situation in PD,
the following equation applies:
TCUFR01 min ¼ LpAðDP  Dpþ sDOÞ
in which TCUFR0–1 min is the maximum TCUF rate, as present
during the first minute of the dwell, Lp is the hydraulic permeability
of the peritoneum, A is the surface area, delta P is the hydrostatic
pressure gradient, delta p is the colloid osmotic pressure gradient,
and sigma is the reflection coefficient. TCUFR0–1 min was calculated
in every patient using the Lineweaver–Burke plot, that is the linear
regression between the reciprocal values of the TCUF obtained
during the SPA and the reciprocal of time.15 For delta P, a constant
value of 9 mmHg was assumed.25 Delta p, the colloid osmotic
pressure gradient was calculated using the formula:
p ¼19:3½SA:1000=68 000:ð4=3Þ þ 0:4
¼ 0:38SA þ 7:72mmHg :
In this equation, SA represents serum albumin (g/l), 68 000 is the
molecular weight of albumin and the factor 1000 converts osmoles
to milliosmoles. The capillary colloid osmotic pressure was consider-
ed to be determined for 75% by the serum albumin concentration.
The value 0.4 was added because of the Gibbs–Donnan equilibirium.25
The crystalloid osmotic pressure gradient sDO was calculated from
glucose and urea concentrations in plasma and dialysate. For each
patient, the reflection coefficient for glucose (s) was calculated
according to the equation
s ¼ ð16=3Þðae=rÞ2  ð20=3Þðae=rÞ3 þ ð7=3Þðae=rÞ4
where ae is the solute radius and r is the pore radius. The solute
radius of glucose was previously determined as 3.12 A˚.26 The
computer simulations as described by Rippe and Stellin27 were used
for the assessment of the pore radii. In this model, the pore sizes
were varied to obtain the best fit between estimated and measured
solute MTACs.26 The reflection coefficient for glucose was calculated
for each type of pore separately. The overall reflection coefficient
then consists of the sum of the reflection coefficients of each pore set
weighted by their respective fractional UF coefficient a. This total
colloid reflection coefficient is mainly determined by glucose,
because the contribution of Naþ and urea are very small compared
to that of glucose, especially when a 3.86% solution is used. The
values reported by Rippe et al. were used27 for a: 0.015 for the
ultrasmall pores, 0.929 for the small pores, and 0.056 for the large
pores. The individually determined values of the TCUF rate in the
first minute and the pressure gradient enabled us to calculate LpA in
every patient.
The osmotic conductance to glucose was calculated as the
product of LpA and sigma.
Statistical analyses
Because of a mainly asymmetric distribution, the results are
expressed as medians and ranges. Spearman’s rank correlation
coefficient was used to analyze correlations. Analysis of variance was
used to compare the three groups with UFF. To further specify the
individual differences among the groups, the post hoc Gabriel test
was used. To compare the groups with and without UFF, the
Wilcoxon’s matched pairs rank sum test and the Mann–Whitney test
were applied. As both tests revealed similar results, the Wilcoxon’s
test was used to present the data. A P-valueo0.05 was considered to
be statistically significant.
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